Item 2.01 Completion of Acquisition or Disposition of Assets.
As previously reported, on
This Amendment No. 1 to Current Report on Form 8-K/A ("Amendment No. 1") is
filed to amend the Current Report on Form 8-K filed with the
The pro forma financial information included in this Amendment No. 1 has been presented for informational purposes only. It does not purport to represent the actual results of operations that the Company and HRA Pharma would have achieved had the companies been combined during the periods presented in the pro forma financial information and is not intended to project the future results of operations that the combined company may achieve after the consummation of the acquisition.
Item 9.01 Financial Statements and Exhibits.
(a) Financial Statements of Businesses Acquired
The audited consolidated financial statements of Héra SAS as of and for the year
ended
(b) Pro Forma Financial Information
The unaudited pro forma condensed combined financial information as of and for
the year ended
(d) Exhibits Exhibit Number Description 23.1 Consent ofKPMG S.A. , independent auditors of Héra SAS. 99.1 Audited consolidated financial statements of Héra SAS as of and for the year endedDecember 31, 2021 . 99.2 Unaudited pro forma condensed combined financial information of the Company after giving effect to the acquisition as of and for the year endedDecember 31, 2021 . 104 Cover Page Interactive Data file (embedded within the Inline XBRL document).
--------------------------------------------------------------------------------
© Edgar Online, source